KLOW Blend is a precision-formulated peptide blend uniting four of the most studied compounds in regenerative and inflammatory research. With 80 mg across four distinct peptides, this single lyophilized vial enables efficient exploration of collagen support, angiogenesis, wound healing, and immune modulation.
Compound Breakdown
GHK-Cu (50 mg)
A copper peptide studied for collagen production, angiogenesis, skin and hair repair, and tissue regeneration.
TB-500 (10 mg)
A thymosin beta-4 fragment investigated for its role in actin binding and recovery of muscle, tendon, and ligament tissue.
BPC-157 (10 mg)
A stable gastric peptide fragment examined for systemic repair activity in tendon, ligament, and gastrointestinal tissue models.
KPV (10 mg)
A tripeptide fragment of alpha-MSH researched for anti-inflammatory and immunomodulatory effects, including cytokine regulation.
Research Applications
KLOW Blend is designed for investigators seeking to:
Study synergistic interactions across regenerative peptides
Compare effects of multi-compound vs. single-compound models
Explore pathways related to wound healing, tissue recovery, and inflammation
Related Categories
The KLOW Blend belongs to the Blends – All-In-One category, designed for multi-compound research efficiency. It brings together compounds from the Tissue & Recovery and Skin & Collagen categories.
Compliance
All Not Labs products are COA-verified and strictly for research use only. Not for human or veterinary use. Our KLOW Blend features a combination of GHK-Cu, TB-500, BPC-157, and KPV Research Peptides. Each component is meticulously sourced and tested for quality assurance, ensuring reliable results for your research endeavors.
FAQ
What is the research focus of KLOW Blend?
KLOW Blend combines four well-studied peptides into a single vial for streamlined investigation of tissue repair, recovery, and inflammation pathways. Researchers may find it valuable for studying how regenerative and anti-inflammatory mechanisms interact within the same model.
Why combine GHK-Cu, TB-500, BPC-157, and KPV?
Each peptide has distinct but complementary roles:
GHK-Cu is studied for collagen production and angiogenesis.
TB-500 is linked to actin modulation and cellular migration.
BPC-157 is explored for connective tissue and gastrointestinal repair.
KPV is investigated for reducing pro-inflammatory cytokine activity.
Together, they allow researchers to test whether combined pathways accelerate repair or improve recovery outcomes compared to single-compound studies.
What biological processes are most relevant for this blend?
Research often looks at wound closure, angiogenesis, extracellular matrix repair, tendon and ligament healing, and modulation of inflammatory cytokines. By covering both regenerative and immune-modulatory mechanisms, KLOW Blend supports multi-angle study designs.
What types of research models are suitable for KLOW Blend?
KLOW Blend may be explored in cell culture systems, animal models of musculoskeletal injury, cutaneous wound repair, or gastrointestinal inflammation. These models allow researchers to observe overlapping effects in vascularization, collagen deposition, and immune response.
How does KLOW Blend compare to purchasing single-compound vials?
Single peptides provide isolated study of one pathway. KLOW Blend reduces experimental complexity by combining peptides into one vial, offering efficiency for studies designed to examine synergy, redundancy, or potential additive effects.
References
See the individual product pages for primary citations and research models:
Reviews
There are no reviews yet.